Table 1 General characteristics of the study population
Total N = 92 | Men (n = 38) | Women (n = 53) | p-value | |
|---|---|---|---|---|
Age (years) | 33.0 (25.5; 42.5) | 33.0 (26.0; 40.0) | 33.0 (25.0; 43.0) | 0.955 |
Diabetes duration (years) | 23.4 (± 9.5) | 22.9 (± 9.0) | 23.7 (± 10.0) | 0.685 |
Age of T1DM onset (years) | 11.0 (5.0; 15.0) | 10.0 (4.0; 15.0) | 11.0 (5.0; 15.0) | 0.955 |
Early onset T1DM (1–10 years of age) | 47.8 (44) | 52.6 (20) | 45.3(24) | 0.479 |
BMI (kg/m2) | 24.8 (± 4.1) | 24.9 (± 3.2) | 24.6 (± 4.7) | 0.790 |
HbA1c (%) | 8.3 (7.5; 9.7) | 8.2 (7.4; 9.3) | 8.8 (7.6; 10.1) | 0.101 |
SBP (mmHg) | 122.3 (± 15.6) | 121.1 (± 11.7) | 123.0 (± 18.0) | 0.580 |
DBP (mmHg) | 75.6 (± 10.2) | 75.1 (± 10.0) | 75.9 (± 10.5) | 0.716 |
LDL-cholesterol (mg/dl) | 94.9 (± 27.2) | 91.6 (± 25.3) | 97.7 (± 28.5) | 0.295 |
eGFR (CKD-EPI) (ml/min/1.73 m2) | 105.5 (80.5; 117.0) | 111.5 (94.0; 117.0) | 99.0 (75.0; 116.0) | 0.084 |
Serum creatinin (mg/dL) | 0.82 (0.75; 0.95) | 0.90 (0.79; 0.97) | 0.78 (0.66; 0.94) | 0.007 |
Albumin-Creatinin Ratio (mg/g) | ||||
Normal | 65.2 (60) | 79.0(30) | 56.6 (30) | 0.035 |
Microalbuminúria | 17.4 (16) | 5.2 (2) | 24.5 (13) | |
Macroalbuminúria | 17.4 (16) | 15.8 (6) | 18.9 (10) | |
Microvascular complications (%) | 62.0 (57) | 47.4 (38) | 71.7 (38) | 0.019 |
Nephropathy (%) | 40.2 (37) | 29.0 (11) | 47.2 (25) | 0.080 |
Retinopathy (%) | 54.4 (50) | 39.5 (15) | 64.2 (34) | 0.020 |
Neuropathy (%) | 10.9 (10) | 5.3 (2) | 13.2 (7) | 0.295 |
Treatments | ||||
Statins | 39.1 (36) | 39.6 (21) | 36.8 (14) | 0.788 |
ACE inhibitor or ARB | 48.9 (45) | 52.8 (28) | 42.1 (16) | 0.313 |
AAS | 5.4 (5) | 7.9 (3) | 1.9 (1) | 0.304 |
Physical activity | 14.1 (13) | 18.4 (7) | 11.3 (6) | 0.375 |
Smoking | 5.8 (5) | 10.8 (4) | 2.1 (1) | 0.162 |